The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional.
Read more
Medpedia Answers
(Oncology/Cancer)Medpedia Answers is a platform for asking and answering questions about health and medicine. Read more.
Can intermediate stage large B cell diffuse Non Hodgkins Lymphoma be cured?
Female
asked Feb 01 at 12:17PM in Oncology/Cancer
-
0Votes
answered Feb 06 at 01:00AMThe FDA approved rituximab (Rituxan, Genentech and Biogen-Idec) in early 2006 for use in the first‑line treatment of patients with diffuse large B-cell, CD20‑positive, non-Hodgkin's lymphoma in combination with CHOP or other anthracycline‑based chemotherapy regimens. The drug increased Overall Survival and progression free survival in treated patients in 3 phase III trials in over 1800 patients over standard chemo. There are several other new drugs in testing phase.
Sign-in
to post an answer to this question.
Related Questions
- I have fillicular lymphoma in my colon. My second chemo treatment was last week.this week I am having bad cramping below my stomach. Is this the chemo attacking the cancer?
- Is there an effect on gastrointestinal hormones after a total colectomy for colon cancer?
- Who is performing DCvac?
- What are hypoechoic cystic lesions
- What is the prognosis of thyroid cancer?
- What type of cell heterogeneity forms in subcutaneous xenografts derived from cultured cell lines (such as HCT16, COLO205, HeLa, etc.)?
- What factors dictate whether a cell is type I or type II regarding the extrinsic apoptotic pathway?
- What is mohs treatment for skin cancer?
- When will we get NOSH and, in the meantime, how can a patient apply to be in its medical trials?
- Is There a Cure For Cancer ?
- »» See All
The content on or accessible through Medpedia.com is for informational purposes only. Medpedia is not a substitute for professional advice or expert medical services from a qualified health professional.
Read more